Tilray Inc
Change company Symbol lookup
Select an option...
TLRY Tilray Inc
AKREX Akre Focus Fund Retail Class
USB U.S. Bancorp
AAPL Apple Inc
AEGN Aegion Corp
AEG Aegon NV
AEE Ameren Corp
AE Adams Resources & Energy Inc
ADXS Advaxis Inc
ADXN Addex Therapeutics Ltd
Go

Health Care : Pharmaceuticals | Small Cap Growth
Based in Canada
Company profile

Tilray Inc is engaged in pharmaceutical sector. The Company is a supplier of cannabis products to pharmaceutical distributors. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Through its subsidiary, FHF Holdings Ltd (Manitoba Harvest) manufactures, markets and distributes hemp-based consumer products. The portfolio of Manitoba Harvest includes Hemp Hearts, Hemp Oil, Hemp Yeah! granola, Hemp Yeah! protein powder and Hemp Bliss milk. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe.

Premarket

Last Trade
Delayed
$19.72
0.02 (0.10%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$19.70
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
473,246

10-day average volume:
39,898,378
473,246

Company Profile

Tilray Inc is engaged in pharmaceutical sector. The Company is a supplier of cannabis products to pharmaceutical distributors. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Through its subsidiary, FHF Holdings Ltd (Manitoba Harvest) manufactures, markets and distributes hemp-based consumer products. The portfolio of Manitoba Harvest includes Hemp Hearts, Hemp Oil, Hemp Yeah! granola, Hemp Yeah! protein powder and Hemp Bliss milk. It also supplies cannabis products to patients in a number of countries spanning five continents through its subsidiaries in Australia, Canada and Germany and it produces medical cannabis in Canada and Europe.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
13.10x
Price/Book (MRQ)
10.84x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

No historic growth available.

Short Interest

December 2020
Current Month
27.7M
Previous Month
26.8M
Percent of Float
24.97%
Days to Cover
1.4430 Days

Share Information

TLRY is in a share class of common stock
Float
66.5M
Shares Outstanding
133.5M
Institutions Holding Shares
185
15.19%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in millions.

Company Officers

  • Michael KruteckCFO
  • Jon Edward LevinCOO
  • Andrew PucherOther
  • Brendan KennedyDir.
  • Michael Auerbach

Address

Insider Trading

During the most recent quarter, 4M shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.